HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endoscopic treatment of vesico-ureteral reflux: Experience of 99 ureteric moieties.

AbstractAIMS:
To study the outcome of endoscopic hyaluronic acid/dextranomer injection in patients with vesico-ureteric reflux (VUR).
MATERIALS AND METHODS:
Sixty-three children were evaluated with a median follow up of 18 months (12-55 months) before injecting hyaluronic acid/dextranomer in a total of 99 ureteric moieties. Median age at presentation was 24 months (6-72 months). Primary VUR was the main presenting diagnosis in 60%. Patients were monitored for urinary tract infection (UTI), glomerular filtration rate (GFR), renal scarring, persistence, or appearance of contra-lateral reflux.
RESULTS:
Grade III VUR was the most common (38%) followed by Grade IV (24%), Grade V (17%), Grade II (14%), and Grade I (7%). Most common cause for VUR was Primary (60%), followed by posterior urethral valve (PUV) (19%), bladder exstrophy (5%), anorectal malformation (ARM), epispadias, and duplex system. Analysis of patients characteristics at presentation revealed renal scarring (40%), split renal functions <35% (35%), recurrent UTI (15%), GFR <50 ml/min/1.73 m(2) (15%), serum creatinine >1.4 mg/dL (10%). Complete resolution (100%) of Grade I and Grade II VUR was achieved after single injection. For Grade III VUR, single injection resolved reflux in 85.5% ureters, 100% resolution was seen after 2(nd) injection. In Grade IV VUR, 1(st) injection resolved VUR in 83.3% ureters, 95.8% ureters were reflux free after 2(nd) injection, and 100% resolution was seen after 3(rd) injection. In Grade V VUR, 94% ureters showed absent reflux after three injections.
CONCLUSION:
Hyaluronic acid/dextranomer injection holds promise even in higher grades of VUR.
AuthorsMinu Bajpai, Ajay Verma, Shasanka S Panda
JournalJournal of Indian Association of Pediatric Surgeons (J Indian Assoc Pediatr Surg) Vol. 18 Issue 4 Pg. 133-5 (Oct 2013) ISSN: 0971-9261 [Print] India
PMID24347865 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: